麻豆传媒

• share
• favorite_border

ATS Breathe Easy - The Latest: Short of Breath, But Not Short of Hope

• share
• favorite_border

ATS Breathe Easy - The Time for Race-Neutral Testing is Now!

• share
• favorite_border

鈥漈B anywhere is TB everywhere,鈥� said tuberculosis expert Philip Hopewell, MD, in the latest ATS Breathe Easy podcast. The U.S. has one of the lowest incidence rates of TB in the world, yet in January, an outbreak caused 2 deaths, and 67 persons developed latent TB in Kansas, which set off alarm bells in public health.

• share
• favorite_border

ATS Breathe Easy - TB Anywhere is TB Everywhere

• share
• favorite_border

ATS Breathe Easy 鈥� One Size Does Not Fit All: Increasing Vaccine Access in Adults

• share
• favorite_border

ATS Breathe Easy - The Latest: Collaborating with Public Health Officials During Outbreaks

• share
• favorite_border

• share
• favorite_border

TS Breathe Easy Podcast 鈥� Vaccine Hesitancy and the Fear of a Measles Outbreak

• share
• favorite_border

Paul Offit, MD, on Vaccines and Measles on Today鈥檚 ATS Breathe Easy Podcast

• share
• favorite_border

ATS Breathe Easy - AI's Impact on Pulmonary Research and Beyond

• share
• favorite_border

ATS Breathe Easy - Biologics: A Breakthrough Treatment for Asthma

• share
• favorite_border

Introducing Teresa Barnes, Pulmonary Fibrosis Warrior

• share
• favorite_border

Pulmonary Fibrosis Warrior to Kick Off ATS Breathe Easy Podcast Relaunch

• share
• favorite_border

We are excited to welcome you to San Francisco for the ATS 2025 International Conference! Journalists will have access to leaders, as well as emerging scientists and clinicians, who are at the forefront of medical breakthroughs and clinical innovation in pulmonary, critical care and sleep medicine.

• share
• favorite_border

• share
• favorite_border

Tuberculosis remains a public health crisis. The World Health Organization鈥檚 Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were newly diagnosed with TB in 2023, the highest number since the organization began global TB monitoring in 1995.

• share
• favorite_border

The latest World Health Organization鈥檚 Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were newly diagnosed with TB in 2023, the highest number since the organization began global TB monitoring in 1995. TB is the leading cause of death among those with HIV /AIDS worldwide. According to the WHO, in 2023, 161,000 people died of HIV-associated TB.

• share
• favorite_border

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic sputum production and cough, claiming three million lives globally each year 鈥攑articularly in low-resource countries 鈥� and is expected to increase due to aging populations and ongoing exposure to risks like tobacco smoke.

• share
• favorite_border

Urgent action is needed, to prevent pneumonia deaths among high-risk groups, particularly children younger than five years and older people, noted the American Thoracic Society and its Forum of International Respiratory Societies (FIRS) partners. New effective preventive interventions are available, but these are still inaccessible in many low- and middle-income countries (LMICs).